YY1 is a crucial transcription factor and plays significant roles in biological processes. However, the mechanisms of YY1 action in ischemia-reperfusion injury and its regulatory role in ferroptosis have not been extensively studied. This study aims to elucidate the molecular mechanism by which NEDD4L-mediated degradation of YY1 through ubiquitination suppresses SLC7A11 transcription, leading to the promotion of cellular ferroptosis and exacerbation of hepatic ischemia-reperfusion injury (IRI), via the integration of multiple omics sequencing datasets. An IRI-I/R mouse model is established, followed by proteomic sequencing to identify proteins that are differentially expressed during IRI. The altered expression of YY1 is validated, and in vivo and in vitro experiments are used to assess its impact on IRI damage. The E3 ligase NEDD4L, which regulates YY1 ubiquitination, is identified and validated via the UbiBrowser 2.0 database. The ubiquitination types of YY1 and its sites are screened and confirmed through in vitro experiments. Transcriptional sequencing of YY1-overexpressing cell lines is conducted to analyze the involvement of the downstream transcription factor SLC7A11 in IRI, followed by validation of its regulatory role. The results show that YY1 is downregulated in liver tissues during IRI and is expressed primarily in liver cells. YY1 overexpression alleviates liver tissue and liver cell IRI both in vitro and in vivo. Upregulation of E3 ligase expression during IRI promotes the K63-linked ubiquitination of YY1 at the K339 site, leading to proteasomal degradation of YY1. RNA-seq analysis and experimental validation demonstrate that YY1 suppresses IRI-induced ferroptosis via the transcriptional regulation of downstream target genes. YY1 positively regulates SLC7A11 transcription, inhibits IRI-induced ferroptosis and ameliorates liver injury. In summary, the E3 ubiquitin ligase NEDD4L facilitates YY1 protein degradation through ubiquitination, suppressing the transcription of the ferroptosis inhibitor SLC7A11, thus pro
[1]Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Hepatobiliary Surg, Huaian 223300, Peoples R China.
[2]Shanghai Tenth Peoples Hosp, Dept Gen Surg, Shanghai 200072, Peoples R China.
[3]Xinjiang Med Univ, State Key Lab Pathogenesis Prevent & Treatment Hig, Urumqi 830054, Peoples R China.
[4]Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Hematol Res Lab, Huaian 223300, Peoples R China.
[5]Xinjiang Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Urumqi 830054, Peoples R China.
[6]Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Gastrointestinal Surg, Huaian 223300, Peoples R China.
(8.0+极速模式)